Gang G Xu

Title: Gang G Xu: Innovator in Tumor Inhibition

Introduction

Gang G Xu is a notable inventor based in Wilmington, DE (US), recognized for his contributions to the field of tumor inhibition. With a total of 2 patents, he has made significant strides in developing innovative pharmaceutical compositions aimed at treating tumorous conditions.

Latest Patents

One of his latest patents is titled "Subject-Specific Tumor Inhibiting Cells and the Use Thereof." This patent discloses a pharmaceutical composition that comprises tumor inhibiting cells (TICs) and outlines a method for producing these TICs. The tumor inhibiting cells can be derived from immune cells, including T cells and NK cells, which are modified to have inactivated Cbl-b gene alleles. These Cbl-bTICs are free from deoxyribonucleic acids exogenous to the immune cells. The immune cells can be isolated using a portable cell isolation and modification device. This innovative approach provides a method for treating tumorous conditions in subjects, offering a subject-specific tumor treatment.

Career Highlights

Throughout his career, Gang G Xu has worked with various companies, including Ezy Biotech LLC and Adaerata, Limited Partnership. His work in these organizations has contributed to advancements in biotechnology and pharmaceutical development.

Collaborations

Gang G Xu has collaborated with notable individuals in his field, including Hua Gu and Adeline Gadzinski. These collaborations have likely enhanced his research and development efforts in tumor inhibition.

Conclusion

Gang G Xu's innovative work in the field of tumor inhibition showcases his dedication to advancing medical science. His patents and collaborations reflect his commitment to developing effective treatments for tumorous conditions.